These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 36323521)

  • 1. Plasma Phosphorylated Tau at Threonine 181 and Neuropsychiatric Symptoms in Preclinical and Prodromal Alzheimer Disease.
    Ghahremani M; Wang M; Chen HY; Zetterberg H; Smith E; Ismail Z;
    Neurology; 2023 Feb; 100(7):e683-e693. PubMed ID: 36323521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing detection of Alzheimer's disease in mild cognitive impairment: a 4-year biomarker study of mild behavioral impairment in ADNI and MEMENTO.
    Ismail Z; Leon R; Creese B; Ballard C; Robert P; Smith EE
    Mol Neurodegener; 2023 Jul; 18(1):50. PubMed ID: 37516848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease.
    Moscoso A; Grothe MJ; Ashton NJ; Karikari TK; Lantero Rodríguez J; Snellman A; Suárez-Calvet M; Blennow K; Zetterberg H; Schöll M;
    JAMA Neurol; 2021 Apr; 78(4):396-406. PubMed ID: 33427873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
    Karikari TK; Pascoal TA; Ashton NJ; Janelidze S; Benedet AL; Rodriguez JL; Chamoun M; Savard M; Kang MS; Therriault J; Schöll M; Massarweh G; Soucy JP; Höglund K; Brinkmalm G; Mattsson N; Palmqvist S; Gauthier S; Stomrud E; Zetterberg H; Hansson O; Rosa-Neto P; Blennow K
    Lancet Neurol; 2020 May; 19(5):422-433. PubMed ID: 32333900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex differences in plasma p-tau181 associations with Alzheimer's disease biomarkers, cognitive decline, and clinical progression.
    Tsiknia AA; Edland SD; Sundermann EE; Reas ET; Brewer JB; Galasko D; Banks SJ;
    Mol Psychiatry; 2022 Oct; 27(10):4314-4322. PubMed ID: 35768637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tau-PET in early cortical Alzheimer brain regions in relation to mild behavioral impairment in older adults with either normal cognition or mild cognitive impairment.
    Naude J; Wang M; Leon R; Smith E; Ismail Z
    Neurobiol Aging; 2024 Jun; 138():19-27. PubMed ID: 38490074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression to Dementia or Reversion to Normal Cognition in Mild Cognitive Impairment as a Function of Late-Onset Neuropsychiatric Symptoms.
    McGirr A; Nathan S; Ghahremani M; Gill S; Smith EE; Ismail Z
    Neurology; 2022 May; 98(21):e2132-e2139. PubMed ID: 35351783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of race, baseline cognition, and APOE on the association of affective dysregulation with incident dementia: A longitudinal study of dementia-free older adults.
    Ebrahim IM; Ghahremani M; Camicioli R; Smith EE; Ismail Z
    J Affect Disord; 2023 Jul; 332():9-18. PubMed ID: 36997127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex differences in Alzheimer's disease: plasma MMP-9 and markers of disease severity.
    Tsiknia AA; Sundermann EE; Reas ET; Edland SD; Brewer JB; Galasko D; Banks SJ;
    Alzheimers Res Ther; 2022 Nov; 14(1):160. PubMed ID: 36324151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mild behavioral impairment correlates of cognitive impairments in older adults without dementia: mediation by amyloid pathology.
    Sun Y; Xu W; Chen KL; Shen XN; Tan L; Yu JT;
    Transl Psychiatry; 2021 Nov; 11(1):577. PubMed ID: 34759274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma neurofilament light, glial fibrillary acid protein, and phosphorylated tau 181 as biomarkers for neuropsychiatric symptoms and related clinical disease progression.
    Rabl M; Zullo L; Lewczuk P; Kornhuber J; Karikari TK; Blennow K; Zetterberg H; Bavato F; Quednow BB; Seifritz E; von Gunten A; Clark C; Popp J
    Alzheimers Res Ther; 2024 Jul; 16(1):165. PubMed ID: 39054505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognition Mediates the Association Between Cerebrospinal Fluid Biomarkers of Amyloid and P-Tau and Neuropsychiatric Symptoms.
    Frank B; Walsh M; Hurley L; Groh J; Blennow K; Zetterberg H; Tripodis Y; Budson AE; O'Connor MK; Martin B; Weller J; McKee A; Qiu W; Stein TD; Stern RA; Mez J; Henson R; Long J; Aschenbrenner AJ; Babulal GM; Morris JC; Schindler S; Alosco ML
    J Alzheimers Dis; 2024; 100(3):1055-1073. PubMed ID: 38995786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma β-Amyloid in Mild Behavioural Impairment - Neuropsychiatric Symptoms on the Alzheimer's Continuum.
    Miao R; Chen HY; Gill S; Naude J; Smith EE; Ismail Z;
    J Geriatr Psychiatry Neurol; 2022 May; 35(3):434-441. PubMed ID: 34036829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mild behavioral impairment and its relation to tau pathology in preclinical Alzheimer's disease.
    Johansson M; Stomrud E; Insel PS; Leuzy A; Johansson PM; Smith R; Ismail Z; Janelidze S; Palmqvist S; van Westen D; Mattsson-Carlgren N; Hansson O
    Transl Psychiatry; 2021 Jan; 11(1):76. PubMed ID: 33500386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychosis in Alzheimer Disease and Elevations in Disease-Relevant Biomarkers.
    Gomar JJ; Koppel J
    JAMA Psychiatry; 2024 Aug; 81(8):834-839. PubMed ID: 38922609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychiatric symptoms differently affect mild cognitive impairment and Alzheimer's disease patients: a retrospective observational study.
    Scaricamazza E; Colonna I; Sancesario GM; Assogna F; Orfei MD; Franchini F; Sancesario G; Mercuri NB; Liguori C
    Neurol Sci; 2019 Jul; 40(7):1377-1382. PubMed ID: 30903419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum.
    Moscoso A; Grothe MJ; Ashton NJ; Karikari TK; Rodriguez JL; Snellman A; Suárez-Calvet M; Zetterberg H; Blennow K; Schöll M;
    Brain; 2021 Feb; 144(1):325-339. PubMed ID: 33257949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between polygenic risk score of Alzheimer's disease and plasma phosphorylated tau in individuals from the Alzheimer's Disease Neuroimaging Initiative.
    Zettergren A; Lord J; Ashton NJ; Benedet AL; Karikari TK; Lantero Rodriguez J; ; Snellman A; Suárez-Calvet M; Proitsi P; Zetterberg H; Blennow K
    Alzheimers Res Ther; 2021 Jan; 13(1):17. PubMed ID: 33419453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychiatric Symptoms and In Vivo Alzheimer's Biomarkers in Mild Cognitive Impairment.
    Spampinato MV; Ulber JL; Fayyaz H; Sullivan A; Collins HR;
    J Alzheimers Dis; 2023; 96(4):1827-1836. PubMed ID: 38007644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of AT(N) biomarkers with neuropsychiatric symptoms in preclinical Alzheimer's disease and cognitively unimpaired individuals.
    Ng KP; Chiew H; Rosa-Neto P; Kandiah N; Ismail Z; Gauthier S
    Transl Neurodegener; 2021 Mar; 10(1):11. PubMed ID: 33789730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.